NewzIntel.com

Blog

  • MIL-OSI United Nations: Readout of the Secretary-General’s meeting with His Holiness Pope Leo XIV

    Source: United Nations secretary general

    The Secretary-General met with His Holiness Pope Leo XIV. They discussed ongoing and future areas of collaboration between the Holy See and the United Nations in their joint efforts to build a peaceful, just and sustainable world.

    His Holiness and the Secretary-General exchanged views on peace and security issues as well as other global priorities, including sustainable development, climate action and artificial intelligence and ways to build on the long legacy of cooperation between the United Nations and the Holy See.

    MIL OSI United Nations News –

  • MIL-OSI United Nations: IOM Ramps Up Emergency Response Amid Deadly Flooding in Nigeria

    Source: International Organization for Migration (IOM)

    Geneva/Mokwa, 11 June 2025 – The International Organization for Migration (IOM), in close coordination with the Government of Nigeria, is responding to severe flooding in Niger State, Nigeria, that has left more than 200 people dead and nearly 10,000 affected. Triggered by heavy rainfall that began on 29 May, the floods have swept through several communities in north-central Nigeria, leaving widespread destruction in their wake.

    According to a joint rapid assessment conducted by IOM, the National Emergency Management Agency (NEMA), the Niger State Emergency Management Agency (NSEMA), and the Nigerian Red Cross Society (NRCS), more than 450 homes have been destroyed.  In addition to the tragic loss of life, over 180 hectares of farmland have been submerged, posing a serious threat to food security and livelihoods just as the lean season approaches.

    “This tragedy has brought unimaginable loss to families who were already living in vulnerable conditions,” said Dimanche Sharon, IOM Chief of Mission in Nigeria. “People have lost their loved ones, their homes, and their livelihoods. Our teams are on the ground, working closely with partners to deliver urgent, life-saving assistance. We are doing everything we can to reach those most in need and help communities begin to recover.”

    In response to the escalating needs, IOM has deployed multisectoral rapid response teams to the affected areas to support data collection, conduct initial damage assessments, and emergency response operations. The Organization has begun distributing 1,000 emergency shelter kits and 500 non-food item packages to displaced families, supporting up to 1,000 families, with priority given to the most vulnerable.

    In parallel, water and sanitation facilities in the affected communities are being assessed for urgent repairs to prevent the spread of waterborne diseases. At the same time, IOM is working closely with government and humanitarian partners to support broader coordination efforts and carry out comprehensive needs assessments, ensuring a flexible and effective response across sectors.

    This response comes at a crucial moment, as communities face mounting risks with the onset of the rainy season. The recent events in Niger State highlight the urgent need to strengthen early warning systems, raise community awareness, and invest in critical infrastructure such as riverbank reinforcement and proper drainage to reduce future risks of flooding.

    “We must move beyond emergency response and focus on long-term solutions,” added Sharon. “Disaster preparedness and climate resilience must be central to our efforts, especially in areas already facing overlapping vulnerabilities.”

    During humanitarian crises, IOM is consistently among the first responders, swiftly mobilizing resources, providing critical data to support the boarder humanitarian system, and coordinating with partners to deliver life-saving assistance, protection, and durable solutions for displaced and vulnerable populations.

    IOM’s ongoing emergency relief efforts in Nigeria are made possible thanks to the support of EU Humanitarian Aid (ECHO).

    For more information, please contact IOM Media Centre.

    MIL OSI United Nations News –

  • MIL-OSI USA: Thompson Announces Appointment of Lucas Gaston to the United States Military Academy

    Source: United States House of Representatives – Congressman Glenn Thompson (5th District Pennsylvania)

    COUDERSPORT, Pa. – U.S. Representative Glenn “GT” Thompson today announced that Mr. Lucas Gaston, of Brookville, Pa. has accepted a fully qualified appointment to the U.S. Military Academy at West Point, N.Y.

    Gaston is a senior at Brookville Area High School. He is the son of Becky and Mike Gaston of Brookville. He is the grandson of Hazel and Joe Gaston of Brookville and Nancy and Ted Fox of Brookville.

    “Lucas is an exceptional young man who has distinguished himself in the classroom, in athletics, and throughout his community,” Rep. Thompson said. “His achievements speak to a deep sense of purpose and a readiness to meet the challenges of the United States Military Academy. I have no doubt that he will thrive at West Point, and I wish him the very best as he begins this exciting new chapter.”

    Gaston is currently serving as the Secretary of his class. He is a track and field and golf athlete, participates in the concert and marching band, is a Special Olympics Volunteer, and a member of the National Honor Society.

     
    ###

    MIL OSI USA News –

  • MIL-OSI USA: Thompson Announces Appointment of Archie Walker to the United States Military Academy

    Source: United States House of Representatives – Congressman Glenn Thompson (5th District Pennsylvania)

    COUDERSPORT, Pa. – U.S. Representative Glenn “GT” Thompson today announced that Ms. Archie Walker, of Lock Haven, Pa. has accepted a fully qualified appointment to the U.S. Military Academy at West Point, N.Y.

    Walker is a senior at Central Mountain High School. She is the daughter of Jennifer and Greg Walker of Lock Haven and she has three siblings: Jackson, Lucy, and Lane Walker.

    “Archie is an accomplished young woman striving to make a difference in her country,” Rep. Thompson said. “She has proven herself on the field and in the classroom. I have no doubt that her determination will serve her well at the Military Academy, and I wish her the very best in this next chapter.”

    Walker is currently serving as the Vice President of the Rotary Club. She is a three-year varsity athlete in soccer, a dual-enrollment student at Commonwealth University, and a member of the National Honor Society.

     
    ###

    MIL OSI USA News –

  • MIL-OSI USA: Thompson Announces Appointment of Bryony Shipe to the U.S. Merchant Marine Academy

    Source: United States House of Representatives – Congressman Glenn Thompson (5th District Pennsylvania)

    COUDERSPORT, Pa. – U.S. Representative Glenn “GT” Thompson today announced that Ms. Bryony Shipe of Ford City, Pa. has accepted a fully-qualified appointment to the U.S. Merchant Marine Academy at Kings Point, N.Y.

    Shipe is a senior at Commonwealth Charter Academy, and is the daughter of Amanda and Lucas Shipe of Ford City. She is the granddaughter of Kathie and Dave Olinger of Manorville, Pa., and Patty and Larry Shipe of Swanton, Md. She has six siblings: Dylayn, Keira, Aynsley, Zayley, Skylyn, and Elijah Shipe.

    “Bryony is a great example of a well-rounded student and active community member,” Rep. Thompsonsaid. “Bryony’s focus on service to others is an extremely valuable attribute that will contribute to her military career. I wish her the very best as she begins this journey.”

    Shipe is an active volunteer and tutors at a local education center. She is a varsity athlete in cross country and swimming, and a co-captain of the varsity swimming and diving team. 

    ###

    MIL OSI USA News –

  • MIL-OSI USA: Thompson, Mannion Introduce EMS Counts Act

    Source: United States House of Representatives – Congressman Glenn Thompson (5th District Pennsylvania)

    WASHINGTON, D.C. – U.S. Representatives Glenn “GT” Thompson (R-PA) and John Mannion (D-NY) today introduced the EMS Counts Act to address the chronic miscounting of emergency personnel.

    The U.S. Department of Labor’s Bureau of Statistics (BLS) current occupational classification system does not properly account for firefighters who are cross-trained as a paramedic or EMT. This oversight results in recognizing cross-training results in a significant and chronic undercount of emergency personnel nationwide, making it challenging to track gaps in emergency services and meet the needs of first responders.

    The EMS Counts Act would require the BLS to revise the Standard Occupational Classification System to accurately reflect the number of paramedics, EMTs, and other first responders throughout communities nationwide.

    “Prior to serving in Congress, I spent decades as a volunteer firefighter and EMT. I recognize and value to the commitment these individuals have to their communities,” Rep. Thompsonsaid. “Correcting outdated classifications is important, because without a accurate count of the number of EMTs, paramedics, and other emergency service providers, it creates a challenge to adequately meet the health and safety needs of our communities.”

    “The bipartisan EMS Counts Act supports our first responders by ensuring they are properly recognized in national workforce data,” Rep. Mannion said. “Firefighters and EMS personnel are often the first on the scene during emergencies, and the current data gap has real consequences for emergency planning, resource allocation, and workplace protections. By fixing this, we’re helping communities become safer, better prepared, and more resilient. I’m grateful to partner with Rep. GT Thompson and for his leadership on this commonsense legislation that honors the dedication of so many in Central New York, the Mohawk Valley, and across the country who put their lives on the line every day.”

    “Fire fighters are proud to serve as the first medical professional to treat many critically ill or injured patients. Medical emergencies are one of fire fighters’ most common types of calls. The BLS’ failure to recognize that EMS is a core component of the fire service has led to incorrect data being used in emergency planning, labor surveys, and health protections for fire-based EMS professionals. The IAFF is proud to support this legislation from Reps. Thompson and Mannion which recognizes that EMS is an intrinsic part of the firefighting profession,” said Edward A. Kelly, International Association of Fire Fighters (IAFF) General President.

    “The bipartisan EMS Counts Act is foundational legislation for the Emergency Medical Services (EMS) community. EMS consists of a diverse group of first responders, including health care practitioners such as Emergency Medical Technicians (EMTs) and paramedics who often serve in dual roles as Firefighter/EMTs and Firefighter/Paramedics. NAEMT applauds Representative Thompson and Representative Mannion’s introduction of the EMS Counts Act that will finally accurately represent the current structure of the Standard Occupational Classification (SOC), the system used by the Department of Labor BLS, which has led to a severe undercounting of EMS personnel across the nation. This data is the basis for funding and policy decisions, so to undercount EMS personnel is to undercut our nation’s ability to provide life-saving and preventive community care. NAEMT urges for passage of the EMS Counts Act,” said Chris Way, National Association of Emergency Medical Technicians (NAEMT) President. 

    MIL OSI USA News –

  • MIL-OSI USA: Thompson Announces Appointment of Adam Bell to the U.S. Naval Academy

    Source: United States House of Representatives – Congressman Glenn Thompson (5th District Pennsylvania)

    COUDERSPORT, Pa. – U.S. Representative Glenn “GT” Thompson today announced that Mr. Adam Bell of State College, Pa. has accepted a fully-qualified appointment to the U.S. Naval Academy at Annapolis, Md.

    Bell is a senior at State College Area High School, and is the son of Elizabeth and Jayce Bell of State College. He is the grandson of  E. Ann Wortman and the Late Jerry Wortman of Warren, Pa., and Janie and Roy Bell of Alturas, Calif. He has two siblings, Samuel and Katelyn Bell.

    Bell is involved in his high school’s culinary program and has represented his school in competitions. He is a varsity athlete in three sports, diving, wrestling, and track, and participates in Model UN.

    “Whether in the kitchen, on the field, or in the classroom, Adam excels in every area,” Rep. Thompsonsaid. “His drive for success will help him excel at the Naval Academy. I wish Adam good luck as he begins this next chapter of his life as a midshipman and student athlete in Annapolis.”

    Bell will continue his athletic pursuits while at the Naval Academy. He has been recruited as a pole vaulter for USNA’s track and field team.

    ###

    MIL OSI USA News –

  • Om Birla pays floral tribute to former speaker K.S. Hegde on his birth anniversary

    Source: Government of India

    Source: Government of India (4)

    Lok Sabha Speaker Om Birla today led a solemn ceremony at Samvidhan Sadan to pay floral tribute to former Speaker K. S. Hegde on his birth anniversary.

    Elected to the Rajya Sabha in 1952, K. S. Hegde served until 1957, when he resigned to join the Mysore High Court as a judge. His illustrious judicial career saw him serve as Chief Justice of the Delhi and Himachal Pradesh High Court and later as a Supreme Court Judge from 1967 until his resignation in 1973. In 1977, Hegde was elected to the Sixth Lok Sabha from Bangalore South Constituency and became Lok Sabha Speaker on July 21, 1977, following Dr. Neelam Sanjiva Reddy’s resignation. After stepping down as Speaker in January 1980, he settled in his native Karnataka, where he passed away on May 24, 1990.

    During the ceremony, a booklet highlighting Hegde’s life and contributions, published

  • MIL-OSI Asia-Pac: LCQ10: Facilitation measures for cross-boundary goods vehicles

    Source: Hong Kong Government special administrative region

    Following is a question by the Hon Yim Kong and a written reply by the Secretary for Transport and Logistics, Ms Mable Chan, in the Legislative Council today (June 11):

    Question:

    It has been reported that the Government will announce the details of Southbound Travel for Guangdong Vehicles within this year, and only non-commercial small passenger vehicles will be allowed to apply under the first phase of implementation. Some members of the logistics and transport industries expect the Government to make good use of the Hong Kong-Zhuhai-Macao Bridge and take the opportunity of implementing Southbound Travel for Guangdong Vehicles to enhance the relevant policy on Guangdong/Hong Kong cross-boundary Mainland goods vehicles, so as to further consolidate Hong Kong’s role as the prominent hub for the Guangdong-Hong Kong-Macao Greater Bay Area, and to drive the development of the Hong Kong International Airport (the airport), container terminals, and the entire logistics industry. In this connection, will the Government inform this Council:

    (1) whether the Government will, in the course of formulating the policy on Southbound Travel for Guangdong Vehicles, discuss with the Mainland authorities the enhancement of the relevant policy on cross-boundary Mainland goods vehicles (including the quota system coordinated by the governments of Guangdong and Hong Kong), so as to facilitate cross-boundary goods vehicles in travelling between the Mainland and Hong Kong; if so, of the details, including the expected time of announcing the relevant policy;

    (2) whether the Government will enhance the application process for southbound cross-boundary Mainland goods vehicles or introduce new measures, e.g. making reference to the existing system of “closed road permits” while streamlining the application process therein, such that a certain number of Mainland goods vehicles will be allowed to reach designated major cargo hubs in Hong Kong (including the cargo terminals of the airport and container terminals) directly via designated routes; and

    (3) whether the Government will make reference to the experience of other places (e.g. the “Green Card system” (a kind of cross-border motor insurance card system) in Europe) and promote a mutual recognition mechanism for motor insurance among Guangdong, Hong Kong and Macao, so as to achieve “one insurance policy for all”?

    Reply:

    President,

    The Transport and Logistics Bureau (TLB) attaches great importance to the development of modern logistics, and is committed to developing Hong Kong into an international smart logistics hub. To this end, the Government promulgated the Action Plan on Modern Logistics Development in 2023, which proposed to enhance Hong Kong’s role as the gateway and key transshipment hub for cargoes to and from the Greater Bay Area (GBA) by improving multimodal transport. In particular, cross-boundary land freight transport is a major mode of freight transport between Hong Kong and other cities in the GBA, as well as an important component of the “rail-sea-land-river” intermodal transport system between Hong Kong and the Mainland. On the other hand, cross-boundary goods vehicles are also a major means for transporting daily supplies and are of crucial importance to the livelihood of Hong Kong people. Hence, the TLB has always placed strong emphasis on improving cross-boundary land freight transport arrangements. In handling matters related to cross-boundary goods vehicles, the TLB always adheres to the policy principle of “maintaining capacity and stability” and takes into account the views of different stakeholders, so as to ensure smooth operation and adequate capacity of cross-boundary land freight transport, thereby providing staunch support for strengthening and enhancing Hong Kong’s status as an international maritime centre, international aviation hub and international logistics hub.

    Having consulted the Financial Services and the Treasury Bureau, and the Transport Department (TD), our reply to various parts of the Hon Yim’s question is as follows:

    (1) and (2) Cross-boundary goods vehicles are subject to the regulation of the quota system which is agreed and jointly administered by the governments of Guangdong and Hong Kong. If the Mainland goods vehicles need to apply for Hong Kong permit/licence, holders of the Mainland goods vehicle quotas must first apply to the relevant Mainland authority for the Mainland Approval Notice (commonly known as MAN) for their goods vehicles. The quota holders should also apply to the TD for vehicle approval and vehicle examination for their goods vehicles; upon passing the vehicle examination, they could proceed with vehicle registration and licensing as well as apply for Closed Road Permit (CRP). The TD would issue CRPs according to the approved boundary crossing(s) recorded on the MAN so that cross-boundary goods vehicles concerned could ply between Guangdong and Hong Kong via the designated boundary crossing(s). Besides, drivers from the Mainland driving the goods vehicles concerned should hold a full Hong Kong driving licence for the corresponding vehicle class(es) (such as light, medium or heavy goods vehicles). From 2022 to April 2025, the number of cross-boundary goods vehicles with valid CRPs maintained at about 10 000, among which goods vehicles from the Mainland have increased.

    Guangdong and Hong Kong have been maintaining close liaison, and will review and enhance relevant facilitation measures for cross-boundary goods vehicles as appropriate subject to the development of freight logistics, local traffic capacity and trade’s responses in both places. Guangdong and Hong Kong also keep reviewing the number of quotas for cross-boundary goods vehicles from time to time. If the Mainland authorities seek to increase the quotas, Hong Kong will expedite the vetting with enhanced efficiency. Besides, the TD has enhanced the arrangement of vehicle approval for cross-boundary goods vehicles with a view to completing the relevant process with enhanced speed. In general, if all the documents required are in order and accurate, the time needed for completion of vehicle approval, examination, registration and licensing, as well as CRP application has been greatly shortened to as fast as three to four weeks.

    (3) The Insurance Authority has been in discussion with relevant authorities and the insurance industry on the insurance arrangement for cross-boundary vehicles, with a view to providing facilitation and appropriate insurance products. Take Northbound Travel for Hong Kong Vehicles as an example, the Government has at the same time implemented the “unilateral recognition” arrangement for cross-boundary motor insurance, which allows Hong Kong private cars driving into Guangdong via the Hong Kong-Zhuhai-Macao Bridge to extend the coverage of their third-party liability insurance purchased from Hong Kong insurers to the Mainland, thereby eliminating the need for separate policies in both places and facilitating travel between Guangdong and Hong Kong. The Government will continue to monitor the development of the cross-boundary freight and logistics industry, and review the relevant measures in a timely manner.

    Ends/Wednesday, June 11, 2025
    Issued at HKT 11:43

    MIL OSI Asia Pacific News –

  • MIL-OSI Asia-Pac: Guangdong, Hong Kong and Macao hold public health exercise in preparation for hosting 15th NG, NGD and NSOG (with photos)

    Source: Hong Kong Government special administrative region

    Guangdong, Hong Kong and Macao hold public health exercise in preparation for hosting 15th NG, NGD and NSOG Issued at HKT 18:35

    The Centre for Health Protection (CHP) of the Department of Health, in collaboration with the health authorities of Guangdong Province and Macao, today (June 11) conducted a public health exercise, code-named “Jingfeng”, to enhance the capacity of the three places to co-operate in preventing and controlling communicable diseases during major sports events. The exercise was held in preparation for the 15th National Games (15th NG), the 12th National Games for Persons with Disabilities (NGD), and the 9th National Special Olympic Games (NSOG), which will be co-hosted by Guangdong, Hong Kong and Macao this November and December.

    The exercise simulated a scenario in which two players participating in the 15th NG basketball competition in Hong Kong were diagnosed with meningococcal infection while they were in the city. An epidemiological investigation revealed that some of their close contacts had already departed Hong Kong for Shenzhen and Macao respectively. In accordance with the established mechanism, Hong Kong immediately notified the health authorities of Guangdong and Macao. The health authorities of the three places promptly traced the cases and implemented appropriate infection control measures to prevent the spread of the communicable disease.

    During the exercise, the CHP, together with the Guangdong Provincial Disease Control and Prevention Administration, the Guangdong Provincial Center for Disease Control and Prevention and the Health Bureau of Macao conducted a drill and exchanged views on communicable disease surveillance, prevention, control and notification mechanisms during the 15th NG, and 12th NGD and 9th NSOG via a video conference. More than 30 officers from the health authorities of the three places participated in the exercise.

    Before the commencement of the exercise, the Director of Health, Dr Ronald Lam, gave a speech. “The 15th NG, and NGD and NSOG are the largest and highest-level national multisport events in the country. It is of great strategic significance for the health authorities of Guangdong, Hong Kong and Macao to jointly organise this exercise on communicable disease prevention and control at the countdown stage of the opening of the Games. Through the simulation, we hope to achieve three major objectives: to strengthen the joint prevention mechanism of the three places; to build a solid risk identification defense; and to consolidate the foundation of event protection. This will allow the top athletes in the country to demonstrate the country’s sports prowess under a ‘zero significant outbreak, zero cross-infections’ condition, and showcase the country’s excellence in public health governance to the world,” he said.

    Dr Lam added that since its establishment, the CHP has organised a total of 32 emergency response exercises and drills, simulating human cases of avian influenza, measles, plagues and Middle East Respiratory Syndrome. As Guangdong, Hong Kong and Macao are geographically and culturally connected, only through close collaboration can the three centres cope with major public health challenges. In the future, the three places will continue to strengthen joint efforts in the prevention and control of communicable diseases. They will maintain communication and collaboration on aspects such as the prevention and control of communicable diseases, and the development of the public health system, with a view to enhancing global health safety standards. They will also fulfil the tripartite co-operation agreement on public health emergencies and the Guangdong-Hong Kong-Macao Health Cooperation Consensus.

    Apart from the health authorities of the three places, representatives from the Medical and Health Office of the Comprehensive Security Department of the Guangdong Provincial Executive Committees for the 15th NG, NGD and NSOG, National Games Coordination Office (Hong Kong) of the Culture, Sports and Tourism Bureau of the Hong Kong Special Administrative Region, the Auxiliary Medical Service, the Fire Services Department and the Hospital Authority have also sent their staff to observe the exercise.

    Ends/Wednesday, June 11, 2025
    Issued at HKT 18:35

    MIL OSI Asia Pacific News –

  • MIL-OSI Asia-Pac: Castle Peak Hospital missing patient found

    Source: Hong Kong Government special administrative region

    Castle Peak Hospital missing patient foundIssued at HKT 14:55

    The following is issued on behalf of the Hospital Authority: The spokesperson for Castle Peak Hospital made the following update today (June 11) regarding a patient leaving the hospital without notification earlier: The 43-year-old female patient who left the hospital without notification yesterday (June 10) has returned to the hospital this morning and is in stable condition.

    MIL OSI Asia Pacific News –

  • MIL-OSI USA: Visit Any Disaster Recovery Center For In-Person FEMA Assistance

    Source: US Federal Emergency Management Agency

    Headline: Visit Any Disaster Recovery Center For In-Person FEMA Assistance

    Visit Any Disaster Recovery Center For In-Person FEMA Assistance

    FRANKFORT, Ky

    –If you are a Kentucky survivor who experienced loss as the result of the severe storms, straight-line winds and tornadoes from May 16-17, 2025, you do not have to go to a Disaster Recovery Center in your own county

    You can receive in-person FEMA assistance at any center

     No appointment is needed

    To find all Disaster Recovery Center locations, including those in other states, go to fema

    gov/drc or text “DRC” and a Zip Code to 43362

    Disaster Recovery Centers are one-stop shops where you can get information and advice on available assistance from state, federal and community organizations

     You can get help to apply for FEMA assistance, learn the status of your FEMA application, understand the letters you get from FEMA and get referrals to agencies that may offer other assistance

    The U

    S

    Small Business Administration representatives and resources from the Commonwealth are also available at the Disaster Recovery Centers to assist you

    FEMA is encouraging Kentuckians affected by the May tornadoes to apply for federal disaster assistance as soon as possible

    The deadline to apply is July 23

    You don’t have to visit a center to apply for FEMA assistance

    There are other ways to apply: online at DisasterAssistance

    gov, use the FEMA App for mobile devices or call 800-621-3362

    If you use a relay service, such as Video Relay Service (VRS), captioned telephone or other service, give FEMA the number for that service

    When you apply, you will need to provide:A current phone number where you can be contacted

    Your address at the time of the disaster and the address where you are now staying

    Your Social Security Number

    A general list of damage and losses

    Banking information if you choose direct deposit

     If insured, the policy number or the agent and/or the company name

    For more information about Kentucky tornado recovery, visit www

    fema

    gov/disaster/4875

    For more information about Kentucky flooding recovery, visit www

    fema

    gov/disaster/4864

    Follow the FEMA Region 4 X account at x

    com/femaregion4

     
    martyce

    allenjr
    Wed, 06/11/2025 – 12:06

    MIL OSI USA News –

  • MIL-OSI USA: NASA Glenn Pitches Science Demonstrations at Lake Erie Crushers Game 

    Source: NASA

    NASA’s Glenn Research Center headed to the ballpark for Education Day with the Lake Erie Crushers on May 15. NASA Glenn staff showcased the science of NASA using portable wind tunnel demonstrations, virtual reality simulations, and other interactives inspired by NASA’s Artemis missions.  

    Guests snapped photos at an “out-of-this-world” selfie station and learned how to take the first step toward a career in the aerospace or space industry through NASA’s internship programs. The mid-day game welcomed 3,575 fans, many who came from local schools on field trips for the special day. 

    MIL OSI USA News –

  • MIL-OSI USA: NASA Glenn Employees Recognized by Astronaut Corps

    Source: NASA

    Four of NASA Glenn Research Center’s employees have received the coveted NASA Silver Snoopy Award. This award, overseen by NASA’s Space Flight Awareness program, is a special honor given to NASA employees and contractors for their outstanding achievements related to flight safety and mission success. It is the astronauts’ personal award to recognize excellence and is given to less than 1% of the workforce annually.  
    Deputy Center Director Dawn Schaible, joined by astronaut Randy Bresnik, presented the awards at the center in Cleveland on May 14. Bresnik was part of a crew in 2009 that delivered 30,000 pounds of essential parts and equipment to the International Space Station. He served as the commander of the space station for Expedition 53 and flight engineer for Expedition 52. 
    The recipients include Rula Coroneos, Joshua Finkbeiner, Tyler Hickman, and Ron Johns. Each of the honorees has played a crucial role in supporting the Artemis campaign, which will explore the Moon and prepare for human missions to Mars. The award recipients have made significant contributions to the success of the Orion spacecraft and its European Service Module and have been dedicated to the safety and success of Artemis I and upcoming Artemis missions.  

    MIL OSI USA News –

  • MIL-OSI USA: NASA’s CODEX Captures Unique Views of Sun’s Outer Atmosphere

    Source: NASA

    Key Points:

    NASA’s CODEX investigation captured images of the Sun’s outer atmosphere, the corona, showcasing new aspects of its gusty, uneven flow.
    The CODEX instrument, located on the International Space Station, is a coronagraph — a scientific tool that creates an artificial eclipse with physical disks — that measures the speed and temperature of solar wind using special filters.
    These first-of-their-kind measurements will help scientists improve models of space weather and better understand the Sun’s impact on Earth.

    Scientists analyzing data from NASA’s CODEX (Coronal Diagnostic Experiment) investigation have successfully evaluated the instrument’s first images, revealing the speed and temperature of material flowing out from the Sun. These images, shared at a press event Tuesday at the American Astronomical Society meeting in Anchorage, Alaska, illustrate the Sun’s outer atmosphere, or corona, is not a homogenous, steady flow of material, but an area with sputtering gusts of hot plasma. These images will help scientists improve their understanding of how the Sun impacts Earth and our technology in space.
    “We really never had the ability to do this kind of science before,” said Jeffrey Newmark, a heliophysicist at NASA’s Goddard Space Flight Center in Greenbelt, Maryland, and the principal investigator for CODEX. “The right kind of filters, the right size instrumentation — all the right things fell into place. These are brand new observations that have never been seen before, and we think there’s a lot of really interesting science to be done with it.”

    NASA’s CODEX is a solar coronagraph, an instrument often employed to study the Sun’s faint corona, or outer atmosphere, by blocking the bright face of the Sun. The instrument, which is installed on the International Space Station, creates artificial eclipses using a series of circular pieces of material called occulting disks at the end of a long telescope-like tube. The occulting disks are about the size of a tennis ball and are held in place by three metal arms.
    Scientists often use coronagraphs to study visible light from the corona, revealing dynamic features, such as solar storms, that shape the weather in space, potentially impacting Earth and beyond.

    “The CODEX instrument is doing something new,” said Newmark. “Previous coronagraph experiments have measured the density of material in the corona, but CODEX is measuring the temperature and speed of material in the slowly varying solar wind flowing out from the Sun.”
    These new measurements allow scientists to better characterize the energy at the source of the solar wind.
    The CODEX instrument uses four narrow-band filters — two for temperature and two for speed — to capture solar wind data. “By comparing the brightness of the images in each of these filters, we can tell the temperature and speed of the coronal solar wind,” said Newmark.
    Understanding the speed and temperature of the solar wind helps scientists build a more accurate picture of the Sun, which is necessary for modeling and predicting the Sun’s behaviors.
    “The CODEX instrument will impact space weather modeling by providing constraints for modelers to use in the future,” said Newmark. “We’re excited for what’s to come.”

    by NASA Science Editorial TeamNASA’s Goddard Space Flight Center, Greenbelt, Md

    CODEX is a collaboration between NASA Goddard Space Flight Center and the Korea Astronomy and Space Science Institute (KASI) with additional contribution from Italy’s National Institute for Astrophysics (INAF).

    MIL OSI USA News –

  • MIL-OSI USA: Storm Duo Churns Over the Pacific

    Source: NASA

    Several weeks into the 2025 eastern Pacific hurricane season, a pair of tropical cyclones churned off the western coast of Mexico. The storms—Barbara and Cosme—are visible in this image, acquired on the afternoon (20:15 Universal Time) of June 9, 2025, by the VIIRS (Visible Infrared Imaging Radiometer Suite) on the NOAA-20 satellite.
    Around the time of this image, Barbara was a Category 1 hurricane with sustained winds of about 120 kilometers (75 miles) per hour, according to the National Hurricane Center. The storm had intensified into a hurricane earlier in the day as it became more organized and formed a partial eyewall. Its run was short-lived, however, as it moved west-northwest over cooler water surfaces. It weakened to a tropical storm by the evening.
    Meanwhile, Tropical Storm Cosme churned nearby with sustained winds of 110 kilometers (70 miles) per hour—close to but not quite hurricane strength—and remained near the hurricane threshold through the evening of June 9. Forecasters called for it to weaken over the next several days.
    Both storms were moving away from Mexico’s mainland. While Cosme stayed well offshore and posed no hazards to land, Barbara was expected to produce dangerous swells and rip currents and deliver gusty winds to coastal areas.
    Barbara was the first hurricane of the eastern Pacific hurricane season, which officially begins on May 15 and continues through November 30. However, tropical cyclones can occur outside this timeframe.
    NASA Earth Observatory image by Michala Garrison, using VIIRS data from NASA EOSDIS LANCE, GIBS/Worldview, and the Joint Polar Satellite System (JPSS). Story by Kathryn Hansen.

    MIL OSI USA News –

  • MIL-OSI USA: DCCA NEWS RELEASE: DCCA DISCIPLINARY ACTIONS (THROUGH MAY 2025)

    Source: US State of Hawaii

    DCCA NEWS RELEASE: DCCA DISCIPLINARY ACTIONS (THROUGH MAY 2025)

    Posted on Jun 10, 2025 in Latest Department News, Newsroom

    STATE OF HAWAIʻI

    KA MOKU ʻĀINA O HAWAIʻI

     

    JOSH GREEN, M.D.

    GOVERNOR

    KE KIAʻĀINA

     

    KA ʻOIHANA PILI KĀLEPA

     

    NADINE Y. ANDO

    DIRECTOR

    KA LUNA HOʻOKELE

     

    DENISE P. BALANAY

    SENIOR HEARINGS OFFICER

    DCCA DISCIPLINARY ACTIONS

    (Through May 2025)

     

    June 10, 2025

    HONOLULU – The state Department of Commerce and Consumer Affairs (DCCA) and its respective state Boards and Commissions released a summary of disciplinary actions through the month of May 2025, taken on individuals and entities with professional and vocational licenses in Hawai‘i. These disciplinary actions include dispositions based upon either the results of contested case hearings or settlement agreements submitted by the parties. Respondents enter into settlement agreements as a compromise to claims and to conserve on the expenses of proceeding with an administrative hearing.

    The DCCA and the Boards and Commissions are responsible for ensuring those with professional and vocational licenses areperforming up to the standards prescribed by state law.

     

     

    Respondent:     Tricia Ann K.C. Mangubat fka Tricia Ann K. Castro

    Case Number:   ACC 2022-22-L

    Sanction:          Voluntary license surrender

    Effective Date:  3-14-25

     

    RICO alleges that Respondent plead guilty in the United States District Court for the District of Hawaii to Conspiracy to defraud the United States and Conspiracy to Commit Bank Fraud, in potential violation of HRS §§ 436B-19(7), 436B-19(8), 436B-19(9), 436B-19(14), 466-9(b)(5), and 466-9(b)(8). (Board approved Settlement Agreement.)

     

     

    Respondent:     Mali Bella Company, LLC dba Mali Bella Construction

    Case Number: CLB 2024-195-L Sanction:          License revocation

    Effective Date: 5-23-25

     

    RICO alleges that Respondent entered into a written contract to renovate and construct a home addition, failed to provide required disclosures, and failed to complete the project as agreed, in potential violation of HRS §§ 444-17(11) and 444-25.5.(Board approved Settlement Agreement.)

     

    Respondent:     Mali Bella Company, LLC dba Mali Bella Construction

    Case Number: CLB 2024-381-L Sanction:          License revocation

    Effective Date: 5-23-25

     

    RICO alleges that Respondent entered into a written contract to renovate a home and failed to provide required disclosures, in potential violation of HRS §§ 444-17(12) and 444-25.5(b)(1), and HAR §§ 16-77-80(a)(3), 16-77-80(a)(5), 16-77-80(a)(6), and 16-77-80(a)(7). (Board approved Settlement Agreement.)

     

    Respondent:     David P. Luedtke

    Case Number: CLB 2024-195-L Sanction:          License revocation

    Effective Date: 5-23-25

     

    RICO alleges that Respondent was the principal RME of Mali Bella Construction (MBC), that MBC entered into a written contract to renovate and construct a home addition, and that MBC failed to provide required disclosures, in potential violation of HRS §§ 444-17(12) and 444-25.5, and HAR § 16-77-71(a). (Board approved Settlement Agreement.)

     

    Respondent:     David P. Luedtke

    Case Number: CLB 2024-381-L Sanction:          License revocation

    Effective Date: 5-23-25

     

    RICO alleges that Respondent was the principal RME of Mali Bella Construction (MBC), that MBC entered into a written contract to renovate a home, and that MBC failed to provide required disclosures, in potential violation of HRS §§ 444-17(12) and 444-25.5, and HAR § 16-77-71(a). (Board approved Settlement Agreement.)

     

    REAL ESTATE COMMISSION

     

    Respondent:     Leeann Starinieri

    Case Number:   REC 2023-461-L

    Sanction:          $1,500 fine, comply with ADLR terms, continue counseling, substance abuse assessment

    Effective Date: 5-30-25

    RICO alleges that on November 7, 2023, Respondent pled no contest to Reckless Driving in the District Court of the Fifth Circuit, Respondent’s driver’s license was administratively forfeited for four years, and that Respondent wrote a letter to RICO stating she quit drinking alcohol and was in counseling, in potential violation of HRS § 436B-19(12). (Commission approved Settlement Agreement.)

     

    Respondent:     Stephen T. Wells

    Case Number:   REC 2025-115-L

    Sanction:          1-year license suspension, 2-year license probation, education course

    Effective Date: 5-30-25

    RICO alleges that on February 27, 2025, Respondent was sentenced in the U.S. District Court for the State of Hawaii for Health Care Fraud, in potential violation of HRS §§ 436B-19(6) and 436B-19(12). (Commission approved Settlement Agreement.)

     

    Respondents:  Hale Nani Realty LLC and Mon-Jiuan Ide

    Case Number:   REC 2024-503-L

    Sanction:          $15,000 fine

    Effective Date: 5-30-25

     

    RICO alleges that it received a referral alleging Respondents’ licenses were inactive since January 1, 2023, due to Respondent Ide, principal broker for Hale Nani Realty LLC, having insufficient continuing education credits, that Respondent Hale Nani Realty LLC’s license was inactive from January 1, 2023 through December 2, 2024, and that Respondent Ide’s license was inactive from January 1, 2023 through November 8, 2024, in potential violation of HRS § 467-7. (Commission approved Settlement Agreement.)

    Respondents:  Iridescent Productions LLC dba Turquoise Hawaii Real Estate and Rebecca Brooke Corby dba Rebecca Corby

    Case Number:   REC 2022-410-L

    Sanction:          $400 fine

    Effective Date: 5-30-25

    The Commission adopted the Hearings Officer’s recommended decision and found and concluded that Respondent violated HRS §§ 436B-19(16) and 436B-19(17). (Commission’s Final Order after contested case hearing.)

    BusinessCheck is an online platform designed to serve as a comprehensive resource for researching licensed professionals. This tool empowers users to verify licenses, review complaint histories and discover when a business was established, all in one place. Please visit businesscheck.hawaii.gov to verify a professional’s license status, confirming their qualifications, compliance with regulations and accountability to a governing body.

     

    # # #

    Media Contact:

    Communications Office

    Department of Commerce and Consumer Affairs

    Phone: 808-586-2760

    Email: [email protected]

    MIL OSI USA News –

  • MIL-OSI USA: President Trump’s militarization of Los Angeles is illegal. Here’s why.

    Source: US State of California 2

    Jun 10, 2025

    LOS ANGELES – Governor Newsom and Attorney General Bonta are standing up all states by filing a lawsuit and request to block President Trump and the Department of Defense’s illegal militarization of Los Angeles and the takeover of a California National Guard (Cal Guard) unit.  The lawsuit and motion for an emergency temporary restraining order are crucial steps in holding President Trump accountable for his unwarranted and illegal overstep and for putting our democracy and our safety at risk. 

    Here’s why the federal takeover of the Cal Guard unit must be stopped:

    🚨The President’s takeover was not just about California — this action puts EVERY state at risk.

    While the President’s rhetoric is aimed at California, his order applies to every state in the country. On June 7, one day after the protests began, President Trump issued a memorandum purporting to authorize the Department of Defense to call up 2,000 National Guard personnel into federal service for a period of 60 days, and declaring a “form of rebellion against the authority of the Government of the United States” and directing the Secretary of Defense to coordinate with state governors and the National Guard to commandeer state militias. 

    This order was not specific to California and suggests that the President could assume control of any state militia. 

    🚨The law the President cited to take over a state guard requires the Governor’s approval.

    The U.S. Constitution and the Title 10 authority the President invoked require that the Governor consent to federalization of the National Guard, which Governor Newsom was not given the opportunity to do prior to their deployment and which he confirmed he had not given shortly after their deployment. The President’s unlawful order infringes on Governor Newsom’s role as Commander-in-Chief of the California National Guard and violates the state’s sovereign right to control and have available its National Guard in the absence of a lawful invocation of federal power.

    🚨There’s no insurrection, no matter how many times Trump says the word out loud. 

    The situation in Los Angeles didn’t meet the criteria for federalization, which includes invasion by a foreign country, rebellion against the authority of the Government of the United States, and being unable to execute federal laws. That is not the case in the Los Angeles area, where local and state law enforcement have remained vigilant and in control and able to subdue unlawful activity. 

    🚨Local law enforcement had it handled, and the federal government wasn’t equipped to step in. 

    By the time the National Guard arrived on Sunday morning, the protests had dissipated thanks to local law enforcement, and the streets were quiet. The President’s Actions and the military presence actually inflamed the very protest and violence it was supposedly meant to suppress. The introduction of a military presence on city streets has only led to larger crowds and more problems for law enforcement to solve.

    🚨Cal Guard has other things to do …like emergency response and drug interdiction.

    The federalization of the California National Guard deprives California of resources to protect itself and its citizens, including those working on drug interdiction at the border, and of critical responders in the event of a state of emergency — such as the January 2025 firestorm in Los Angeles, which Cal Guard responded to.   

    🚨You can’t threaten to arrest a Governor, just because you don’t agree with them.

    We live in a democracy — and the President’s actions and subsequent threats put it at risk. As Governor Newsom said, President Trump’s actions here are “an unmistakable step towards authoritarianism.”

    Watch the Governor speak about the lawsuit here.

    Press releases, Recent news

    Recent news

    Jun 10, 2025

    News “Turning the military against American citizens” What you need to know:  Standing up for American citizens and the Nation’s foundational ban on martial law in peacetime, California Governor Newsom and Attorney General Bonta are requesting the court step in to…

    Jun 9, 2025

    News What you need to know: California is surging mutual aid resources to support law enforcement as they clean up the actions caused by President Trump. LOS ANGELES – Moving quickly to support local response to federal actions that have caused unrest in Los Angeles,…

    Jun 9, 2025

    News “An unmistakable step toward authoritarianism” What you need to know: Standing up for state sovereignty throughout the nation, California Governor Newsom and Attorney General Bonta are suing the Trump administration for its illegal takeover of the California…

    MIL OSI USA News –

  • MIL-OSI USA: DLNR News Release-Dredging Begins of Lava Inundated Pohoiki Boat Ramp, June 10, 2025

    Source: US State of Hawaii

    DLNR News Release-Dredging Begins of Lava Inundated Pohoiki Boat Ramp, June 10, 2025

    Posted on Jun 10, 2025 in Latest Department News, Newsroom

     

    STATE OF      HAWAIʻI

    KA MOKU ʻĀINA O HAWAIʻI

     

    DEPARTMENT OF LAND AND NATURAL RESOURCES

    KA ‘OIHANA KUMUWAIWAI ‘ĀINA

     

    JOSH GREEN, M.D.
    GOVERNOR

     

    DAWN CHANG
    CHAIRPERSON

    DREDGING BEGINS OF LAVA INUNDATED POHOIKI BOAT RAMP

    Blessing Highlights Community Involvement

     

    FOR IMMEDIATE RELEASE 

    June 10, 2025

     

    PUNA DISTRICT, Hawai‘i Island  – Dredging work began today to restore access to the lava-barricaded Pohoiki Boat Ramp, eight years after lava from an eruption of Kīlauea rendered it unusable.

     

    On Monday, hundreds of people gathered for a community celebration and blessing at the top of the ramp, which by November is expected to be clear of an estimated 42,000 cubic yards of black sand and boulders. That’s about 22,000 full-sized pickup truck beds.

     

    DLNR Chair Dawn Chang, speaking before the blessing, commented, “This is a day of celebration to recognize the collaboration of the community, elected officials and DLNR working together to support this project. The Pohoiki Boat Ramp is a piko, or focal point for this community. Fishing is a huge part of the greater Puna community and commercial, recreational and subsistence fishers have been waiting patiently for this work to begin. The million-dollar question is what took so long?”

     

    Even before the eruption, Finn McCall, the head engineer with the DLNR Division of Boating and Ocean Recreation (DOBOR), made multiple visits to Pohoiki. Immediately after the eruption stopped, McCall continued making further visits to Pohoiki to shift the strategy in addressing ramp needs. “Boy, this has been a long journey,” he remarked. We tried looking at sites from Kapoho all the way to Kalapana. Sand and boulders continued to fill the entire bay, but once that stopped, we began focusing on restoring the Pohoiki ramp.”

     

    The state had hoped for more federal support to approve removal of most of the volcanic debris in Pohoiki Bay, but FEMA was only able to approve restoration of the boat ramp entrance channel. Then it took dogged efforts by state lawmakers from the district to convince the rest of the legislature that opening the Pohoiki boat ramp was the top priority for people in the district.

     

    Chang singled out the efforts of state Senator Joy San Buenaventura and state Representative Greggor Ilagan in getting $5.4 million of state funding for the dredging. The total project cost came in at $9.28 million, which means the $2.9 million shortfall is being covered by DOBOR’s Boating Special Fund, which derives its revenues almost entirely from boating user fees.

     

    In remarks during the blessing ceremony, Sen. San Buenaventura said, “We needed people to understand how much it cost in fuel just to bring all our boats from the Wailoa Small Boat Harbor in Hilo, the nearest boating facility, out to Puna to they could fish to feed and support their families.”

     

    She and Rep. Ilagan often pointed out it was akin to only having one small boat ramp for all of O‘ahu. “In 2021, I was also advocating for the alternate highway route, as that was the number-one issue that people voted on during town hall meetings. In 2022 the community reprioritized my priorities and made the Pohoiki Boat Ramp number one.”

     

    Chang fielded letter after letter, comment after comment from upset and frustrated fishers, some of whom had to give up their generational livelihoods of fishing because it became too expensive. Family members with lineal connections to the coastline were not able to fish, either. She and every single speaker singled out the community for not giving up and pushing to have Pohoiki restored.

     

    As did the consulting company and contractor hired to do the work. Kyle Kaneshiro of Limtiaco Consulting commented, “This has been one of the most eye-opening, humbling projects I’ve ever worked on. The community made everything so easy. This is not an easy project, but the community got everyone together.”

     

    Guy DiBartolo from Goodfellows Bros. Inc., added, “I’ve been to many ground blessings and ceremonies. This one for me, stands out as something unique and special, seeing the community’s involvement over many months and years.”

     

    For many people, like DLNR First Deputy Ryan Kanaka‘ole, Pohoiki stirs up fond childhood memories. “Summertime for me was coming down here, making the two-hour drive each way from Kaʻū with my father to dive, surf, or just relax. This day makes me remember my dad. He didn’t have a house, but he had a car and I’ll never forget those days spent at Pohoiki.”

     

    The contractor has nine months to complete the project but expects to be finished in November.

     

    # # #

     

    RESOURCES

    (All images/video Courtesy: DLNR)

     

    HD video – Pohoiki Boat Ramp Dredging Blessing (June 9, 2025):

    https://www.dropbox.com/scl/fi/kw102jfqjg9w20upm9bsr/Pohoiki-Dredging-Project-Blessing-June-9-2025.mp4?rlkey=p3dz85napmmocpeivp0c45zj0&st=g7w1fs9s&dl=0

     

    HD video – Pohoiki dredging project blessing media clips (June 9, 2025):

    https://www.dropbox.com/scl/fi/hzi3qkgl7t3gkaaisinb6/Pohoiki-dredging-project-blessing-media-clips-June-9-2025.mp4?rlkey=jca3f5ys756051odrc32vzuw4&st=fmke94pp&dl=0

    (Shot sheet/transcriptions attached)

     

    Photographs – Pohoiki dredging project blessing (June 9, 2025):

    https://www.dropbox.com/scl/fo/kedkashm6iqvkt9q7l7v6/AD3MEi0Yyw70FEu516nwrQ0?rlkey=c4c37j39ftlugmkq0hzh8cws6&st=n4fne779&dl=0

     

     

    Media Contact: 

    Dan Dennison 

    Communications Director

    Hawai‘i Dept. of Land and Natural Resources

    808-587-0396 

    [email protected] 

    MIL OSI USA News –

  • MIL-OSI: Inception Growth Acquisition Limited Announces Extension of Business Combination Period

    Source: GlobeNewswire (MIL-OSI)

    New York, June 11, 2025 (GLOBE NEWSWIRE) — Inception Growth Acquisition Limited (NASDAQ: IGTA, the “Company”), a publicly traded special purpose acquisition company, announced today that at its annual meeting of stockholders on June 5, 2025 (the “Meeting”), the Company’s stockholders voted in favor of, among others, the proposals to amend (i) its amended and restated certificate of incorporation; and (ii) the investment management trust agreement with Continental Stock Transfer & Trust Company, giving the Company the right to extend the date on which to commence liquidating the trust account established in connection with the Company’s initial public offering (the “Trust Account”)  by four (4) times for an additional one (1) month each time from June 13, 2025 to October 13, 2025 by depositing into the trust account an aggregate amount equal to $0.075 multiplied by the number of common stock issued in the Company’s initial public offering that has not been redeemed for each one-month extension. The purpose of the extension is to provide additional time for the Company to complete a business combination.

    Contact

    Inception Growth Acquisition Limited
    Investor Relationship Department
    (315) 636-6638

    The MIL Network –

  • MIL-OSI: Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 11, 2025 (GLOBE NEWSWIRE) — Apollo Technology Capital Corporation (“Apollo Capital”), which together with its affiliates and associates collectively is one of the largest shareholders of MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs”, or the “Company”), owning approximately 3% of the Company’s common stock, today issued a presentation to set forth their ambitious plan to grow your investment and help turn MediPharm around.

       
    • Outlines Commitment to Immediately and Aggressively Execute on Action Plan to 10X+ Share Price and Create Value for All Shareholders
    • Details Specific and Measurable Initiatives to Save MediPharm Labs from Insolvency at the Hands of Greedy, Reckless, and Maligned Leaders
    • Sets Forth Plan to Stop Exorbitant Executive Compensation Pay-for-Failure and End 3 Years of Value Destructive Actions
    		  
       

    THE TIME TO ACT IS NOW. VOTE THE GOLD CARD TODAY.

    SHAREHOLDERS ARE URGED TO PROTECT THEIR INVESTMENT BY VOTING THE GOLD PROXY CARD “FOR” APOLLO CAPITAL’S SIX HIGHLY-QUALIFIED DIRECTOR NOMINEES AND DISREGARD MEDIPHARM LABS’ GREEN PROXY CARD.

    TOGETHER LET’S SAVE MEDIPHARM AND DELIVER THE VALUE THAT SHAREHOLDERS DESERVE.

    View the Presentation at https://www.curemedipharm.com/historical-filing/investor-presentation.

    For more information on our detailed value creation plan and instructions on how to vote, please see our website www.curemedipharm.com.

    Contacts

    For Shareholders:
    Carson Proxy
    North American Toll-Free Phone: 1-800-530-5189
    Local or Text Message: 416-751-2066 (collect calls accepted)
    E: info@carsonproxy.com

    For Media:
    media@curemedipharm.com

    This solicitation is being made by and on behalf of Apollo Capital, who, as of the date of this Circular, beneficially owns or controls, directly and indirectly through its wholly-owned subsidiary, Nobul Technologies Inc., 12,491,500 common shares of the Company (“Common Shares”), representing approximately 3% of the total Common Shares issued and outstanding, and not by the management of the Company.

    Legal Disclosures

    Information in Support of Public Broadcast Exemption under Canadian Law

    In connection with the annual general and special meeting (the “Annual Meeting”) of shareholders of MediPharm, Apollo Capital has filed an amended and restated dissident information circular dated May 15, 2025 (the “Circular”), as amended and supplemented by an addendum to the Circular subsequently filed by Apollo Capital and Patrick McCutcheon (together, the “Concerned Stakeholder”) dated June 4, 2025 (the “Addendum” and together with the Circular, the “Amended Circular”), each in compliance with applicable corporate and securities laws. The Concerned Stakeholder has provided in, or incorporated by reference into, this press release the disclosure required under section 9.2(4) of NI 51-102 – Continuous Disclosure Obligations (“NI 51-102”) and the corresponding exemption under the Business Corporations Act (Ontario), and has filed the Amended Circular, available under MediPharm’s profile on SEDAR+ at www.sedarplus.ca. The Amended Circular contains disclosure prescribed by applicable corporate law and disclosure required under section 9.2(6) of NI 51-102 in respect of the Concerned Stakeholder’s director nominees, in accordance with corporate and securities laws applicable to public broadcast solicitations. The Amended Circular is hereby incorporated by reference into this press release and is available under MediPharm’s profile on SEDAR+ at www.sedarplus.ca. The registered office of the Company is 151 John Street, Barrie, Ontario, Canada L4N 2L1.

    SHAREHOLDERS OF MEDIPHARM ARE URGED TO READ THE AMENDED CIRCULAR CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION. Investors and shareholders are able to obtain free copies of the Amended Circular and any amendments or supplements thereto and further proxy circulars at no charge under MediPharm’s profile on SEDAR+ at www.sedarplus.ca. In addition, shareholders are also able to obtain free copies of the Amended Circular and other relevant documents by contacting the Concerned Stakeholder’s proxy solicitor, Carson Proxy Advisors Ltd. (“Carson Proxy”) at 1-800-530-5189, local (collect outside North America): 416-751-2066 or by email at info@carsonproxy.com. Finally, the Amended Circular is available on this website https://www.curemedipharm.com/historical-filing/investor-flyer.

    Proxies may be revoked in accordance with subsection 110(4) of the Business Corporations Act (Ontario) by a registered shareholder of Company shares: (a) by completing and signing a valid proxy bearing a later date and returning it in accordance with the instructions contained in the accompanying form of proxy; (b) by depositing an instrument in writing executed by the shareholder or by the shareholder’s attorney authorized in writing; (c) by transmitting by telephonic or electronic means a revocation that is signed by electronic signature in accordance with applicable law, as the case may be: (i) at the registered office of the Company at any time up to and including the last business day preceding the day the Annual Meeting or any adjournment or postponement of the Annual Meeting is to be held, or (ii) with the chair of the Annual Meeting on the day of the Annual Meeting or any adjournment or postponement of the Annual Meeting; or (d) in any other manner permitted by law. In addition, proxies may be revoked by a non-registered holder of Company shares at any time by written notice to the intermediary in accordance with the instructions given to the non-registered holder by its intermediary. It should be noted that revocation of proxies or voting instructions by a non-registered holder can take several days or even longer to complete and, accordingly, any such revocation should be completed well in advance of the deadline prescribed in the form of proxy or voting instruction form to ensure it is given effect in respect of the Annual Meeting.

    The costs incurred in the preparation and mailing of any circular or proxy solicitation by the Concerned Stakeholder and any other participants named herein will be borne directly and indirectly by Apollo Capital. However, to the extent permitted under applicable law, Apollo Capital intends to seek reimbursement from the Company of all expenses incurred in connection with the solicitation of proxies for the election of its director nominees at the Annual Meeting.

    This press release and any solicitation made by the Concerned Stakeholder is, or will be, as applicable, made by such parties, and not by or on behalf of the management of the Company. Proxies may be solicited by proxy circular, mail, telephone, email or other electronic means, as well as by newspaper or other media advertising and in person by managers, directors, officers and employees of the Concerned Stakeholder who will not be specifically remunerated therefor. In addition, the Concerned Stakeholder may solicit proxies by way of public broadcast, including press release, speech or publication and any other manner permitted under applicable Canadian laws, and may engage the services of one or more agents and authorize other persons to assist it in soliciting proxies on their behalf.

    Apollo Capital has entered into an agreement with Carson Proxy for solicitation and advisory services in connection with the solicitation of proxies by the Concerned Stakeholder for the Annual Meeting, for which Carson Proxy will receive a fee from Apollo Capital not to exceed $250,000, together with reimbursement for reasonable and out-of-pocket expenses. Apollo Capital has also engaged Gasthalter & Co. LP (“G&Co”) to act as communications consultant to provide the Concerned Stakeholder with certain communications, public relations and related services, for which G&Co will receive, from Apollo Capital, a minimum fee of US$75,000 in addition to a performance fee of US$250,000 in the event that the Concerned Stakeholder’s nominees make up a majority of the board of directors of MediPharm (the “Board”) following the Annual Meeting, plus excess fees, related costs and expenses.

    No member of the Concerned Stakeholder nor any of their respective associates or affiliates has or has had any material interest, direct or indirect, in any transaction since the beginning of the Company’s last completed financial year or in any proposed transaction that has materially affected or will or would materially affect the Company or any of the Company’s affiliates. No member of the Concerned Stakeholder nor any of their respective associates or affiliates has any material interest, direct or indirect, by way of beneficial ownership of securities or otherwise, in any matter to be acted upon at the Annual Meeting, other than setting the number of directors and the election of directors to the Board.

    Cautionary Statement Regarding Forward-Looking Statements

    This press release contains forward‐looking statements. All statements contained in this filing that are not clearly historical in nature or that necessarily depend on future events are forward‐looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “plan,” and similar expressions are generally intended to identify forward‐looking statements. These statements are based on current expectations of the Concerned Stakeholder and currently available information. They are not guarantees of future performance, involve certain risks and uncertainties that are difficult to predict, and are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements contained herein are made only as of the date hereof and the Concerned Stakeholder disclaims any intention or obligation to update or revise any such forward-looking statements to reflect events or circumstances that subsequently occur, or of which the Concerned Stakeholder hereafter becomes aware, except as required by applicable law.

    Hashtags: #ShareholderActivism #CorporateGovernance #InvestorProtection #Investor Alert #Investor Fraud #FinancialRegulation #CorporateCrime #FinancialCrime #HomelandSecurity #DHS #OpioidCrisis #OpioidEpidemic #OpioidLitigation #OpioidVictims #BMO #DEA #ONDCP

    The MIL Network –

  • MIL-OSI: TruGolf Announces Acquisition of mlSpatial

    Source: GlobeNewswire (MIL-OSI)

    Salt Lake City, Utah, June 11, 2025 (GLOBE NEWSWIRE) — TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, has announced that it has executed a definitive agreement to acquire mlSpatial, a renowned AI and machine learning engineering firm. This strategic acquisition aims to advance the integration of artificial intelligence within TruGolf’s industry-leading products, including the Apogee Launch Monitor, Launchbox, Multisport Arcade, and E6 Apex.

    The collaboration between TruGolf and mlSpatial began in March 2024 with a licensing agreement to co-develop an AI engine enhancing the 9-axis spin accuracy of TruGolf’s Apogee Launch Monitor. Building upon this successful partnership, the full acquisition of mlSpatial will enable TruGolf to seamlessly incorporate advanced AI technologies across its entire product suite, delivering unparalleled user experiences, training suggestions, and player insights.

    “We are very excited to bring mlSpatial and its AI and machine learning technology into the TruGolf family,” said Chris Jones, TruGolf CEO. He continued, “Acquiring mlSpatial marks a significant milestone in our commitment to revolutionize golf simulation through cutting-edge AI integration. This acquisition empowers us to explore innovative applications of AI across our ecosystem, enhancing realism and interactivity for our users while lowering development costs.”

    Josh Pomazal, founder of mlSpatial, expressed enthusiasm about the acquisition: “We’re excited to leverage TruGolf’s extensive real-time data, collected daily, to continually refine our products with the advanced machine learning and AI models we’ve developed over the years.”

    This acquisition solidifies our deep commitment to innovation and aligns with the broader industry trend of significant investments in AI infrastructure. Notably, in January 2025, President Donald Trump announced a private-sector initiative, the Stargate Project, aiming to invest up to $500 billion in AI infrastructure within the United States. This substantial investment underscores the rapid progress and importance of AI technologies across various sectors.

    reuters.com

    TruGolf’s acquisition of mlSpatial positions the company at the forefront of AI-driven innovation in golf simulation, promising enhanced performance and immersive experiences for enthusiasts worldwide.

    For more information, please visit www.trugolf.com.

    About TruGolf Holdings

    TruGolf is a golf technology company, committed to making golf, easy. From innovative uses for AI to build content and enhance its image and spatial analysis, to gamified golf improvement plans, TruGolf is an industry leader in the growing technological revolution in the sport of golf. Since its founding, TruGolf has redefined what is possible in golf through technology. TruGolf’s suite of Hardware, Software, and Web Products make it easier to Play, Improve, and Enjoy the game of golf.

    Forward-Looking Statements

    Some of the statements in this release are forward-looking statements, which involve risks and uncertainties. Forward-looking statements include, without limitation, whether the Company’s compliance plan will be accepted by Nasdaq and the Company’s expected future cash needs. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including ”believes,” ”estimates,” ”anticipates,” ”expects,” ”plans,” ”projects,” ”intends,” ”potential,” ”may,” ”could,” ”might,” ”will,” ”should,” ”approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors. Any forward-looking statements contained in this release speak only as of its date. The Company undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the SEC, which are available on the SEC’s website, www.sec.gov. 

    Media Contacts:

    TruGolf: Michael Bacal: Phone: 917-886-9071; mbacal@darrowir.com Web: TruGolf.com LinkedIn: @TruGolf

    The MIL Network –

  • MIL-OSI: Siebert Financial Deepens Tech Strategy with FusionIQ Investment

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) — Siebert Financial Corp. (NASDAQ: SIEB) today announced a meaningful investment and strategic partnership with FusionIQ, a leading cloud-native digital wealth management platform. Under the agreement, Siebert will deploy FusionIQ’s technology to enhance its digital offerings and streamline end-to-end investment workflows across its growing client base.

    This move aligns with Siebert’s broader strategy to prioritize technology investment and forge strategic alliances to better serve its clients. The partnership enables Siebert to offer modular digital solutions that include hybrid advice, self-directed investing, and multi-custodian integration.

    “This partnership marks a pivotal step in reshaping our digital footprint,” said John J. Gebbia, Chief Executive Officer of Siebert Financial Corp. “It’s an investment that is positioning Siebert as a digital-first partner for the next generation of investors.”

    “We’re thrilled to integrate FusionIQ’s leading digital wealth management solutions with Siebert’s client offerings,” said John Kimbro, CTO of FusionIQ. “This partnership supports our shared mission to deliver financial freedom to everyone—through intuitive, scalable tools that meet each investor’s unique needs.”

    “Our partnership with Siebert Financial Corp. reflects a shared vision for the future of wealth management and investing tools—one that is inclusive, digital, and built for the next generation of investors,” said Eric Noll, CEO of FusionIQ. “With their forward-looking leadership and deep client relationships, Siebert is uniquely positioned to help us expand access to modern investing solutions. This is just the beginning—together, we’ll continue to broaden our reach, enhance our offerings, and redefine how wealth is built and managed in a digital-first world.”

    John M. Gebbia, Co-CEO of Muriel Siebert & Co. LLC, added, “We’re thrilled to integrate FusionIQ’s award-winning platform with Siebert. This collaboration accelerates our commitment to delivering personalized, tech-driven experiences to our client base. Our goal is clear: empower clients with tools that reflect today’s expectations and tomorrow’s ambitions.”

    About Siebert Financial Corp.
    Siebert is a diversified financial services company and has been a member of the NYSE since 1967, when Muriel Siebert became the first woman to own a seat on the NYSE and the first to head one of its member firms.

    Siebert operates through its subsidiaries Muriel Siebert & Co., LLC, Siebert AdvisorNXT, LLC, Park Wilshire Companies, Inc., RISE Financial Services, LLC, Siebert Technologies, LLC, and StockCross Digital Solutions, Ltd, and Gebbia Media LLC. Through these entities, Siebert provides a full range of brokerage and financial advisory services, including securities brokerage, investment advisory and insurance offerings, securities lending, and corporate stock plan administration solutions, in addition to entertainment and media productions. For over 55 years, Siebert has been a company that values its clients, shareholders, and employees. More information is available at www.siebert.com.

    Cautionary Note Regarding Forward-Looking Statements
    The statements contained in this press release that are not historical facts, including statements about our beliefs and expectations, are “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements preceded by, followed by, or that include the words “may,” “could,” “would,” “should,” “believe,” “expect,” “anticipate,” “plan,” “estimate,” “target,” “project,” “intend” and similar words or expressions. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements.

    These forward-looking statements, which reflect beliefs, objectives, and expectations as of the date hereof, are based on the best judgment of the management of Siebert. All forward-looking statements speak only as of the date on which they are made. Such forward-looking statements are subject to certain risks, uncertainties and assumptions relating to factors that could cause actual results to differ materially from those anticipated in such statements, including, without limitation, the following: economic, social and political conditions, global economic downturns resulting from extraordinary events; securities industry risks; interest rate risks; liquidity risks; credit risk with clients and counterparties; risk of liability for errors in clearing functions; systemic risk; systems failures, delays and capacity constraints; network security risks; competition; reliance on external service providers; new laws and regulations affecting Siebert’s business; net capital requirements; extensive regulation, regulatory uncertainties and legal matters; failure to maintain relationships with employees, customers, business partners or governmental entities; the inability to achieve synergies or to implement integration plans; and other consequences associated with risks and uncertainties detailed in Part I, Item 1A – Risk Factors of Siebert’s Annual Report on Form 10-K for the year ended December 31, 2024, and Siebert’s filings with the SEC.

    Siebert cautions that the foregoing list of factors is not exclusive, and new factors may emerge, or changes to the foregoing factors may occur that could impact its business. Siebert undertakes no obligation to publicly update or revise these statements, whether as a result of new information, future events, or otherwise, except to the extent required by the federal securities laws.

    Media Contact:
    Deborah Kostroun, Zito Partners
    deborah@zitopartners.com
    +1 (201) 403-8185

    The MIL Network –

  • MIL-OSI: Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences

    Source: GlobeNewswire (MIL-OSI)

    PALM BEACH, Fla., June 11, 2025 (GLOBE NEWSWIRE) — FN Media Group News Commentary – The global oncology market is undergoing rapid growth, mainly due to the increasing number of cancer cases around the world. The World Health Organization estimates there will be over 35 million new cancer cases by 2050, a massive 77% increase from the estimated 20 million cases in 2022. This rising occurrence of cancer has been attributed to lifestyle changes in an increasingly geriatric population in both developed countries and emerging economies. Environmental factors such as pollution and the high penetration of microplastics, a potential carcinogen, are also contributing to the growing number of cancer cases. As the global burden of cancer continues to go up, government and private organizations are increasing funding in both healthcare infrastructure and investment into research and development of therapeutics and potential cures for various kinds of cancers. Many federal early detection programs have been launched with large players in the pharmaceutical sector looking to increase the number of clinical trials and drug discovery studies undertaken. These innovations are propelling market expansion, with the sector expected to witness significant growth in the coming years as new technologies and therapies continue to emerge. A new research report from BioSpace, said the global oncology market size was USD 321.19 billion in 2024, and calculated at USD 356.20 billion in 2025 is expected to reach around USD 903.81 billion by 2034, growing at a CAGR of 10.9% for the forecasted period. the development of the global healthcare infrastructure and cancer continuing to be one of the leading causes of death worldwide drives growth in the global oncology market. Active oncology biotech and pharma companies in the markets this week include Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC), Novartis AG (NYSE: NVS), BioNTech SE (NASDAQ: BNTX), Arvinas, Inc. (NASDAQ: ARVN), Pfizer Inc. (NYSE: PFE).

    The report said: “Innovations in cancer treatments include advancements in immunotherapy and precision medicine (which include targeted therapies), and the various applications of artificial intelligence. Some examples of novel oncological treatments include kinase and checkpoint inhibitors, monoclonal antibodies, and CAR-T cell therapy. These therapeutics mobilize the body’s immune system in new ways to fight cancer. As early diagnostic techniques improve, certain kinds of cancers, such as breast cancer, melanoma, and thyroid cancer, can be cured more frequently. Techniques such as liquid biopsy, biomarker-based testing and breakthroughs such as next-generation sequencing (NGS) are enhancing the ability to diagnose cancer at an early stage. As investment continues to grow in the oncology sector, new treatments are expected to improve the remission and survival rates of patients battling this disease and provide a boost to growth in the global oncology market.”

    Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC) Names New CEO to Accelerate Momentum in Immunotherapy Programs — Oncolytics Biotech ® Inc., ($ONCY $ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Jared Kelly as Chief Executive Officer and a member of its Board of Directors.

    Mr. Kelly is a successful biotech executive who has proven expertise in transformative deals and corporate strategy. Most recently, he played a central role in orchestrating the sale of Ambrx Biopharma to Johnson & Johnson for $2 billion. Prior to Ambrx, he advised multiple leading-edge biotech companies on M&A and licensing transactions at highly respected law firms, including Lowenstein Sandler LLP and Kirkland & Ellis LLP. He is a JD and LLM graduate of Georgetown Law.

    “Mr. Kelly’s vision and track record is an extraordinary fit with the standout clinical data pelareorep has generated to date,” said Wayne Pisano, Chair of Oncolytics’ Board of Directors and outgoing Interim CEO. “We believe Mr. Kelly’s well-documented ability to prioritize clinical program development, execute successful financings, and attract the attention of large industry peers will help maximize Oncolytics’ potential to deliver transformative outcomes for patients and exceptional value for investors.”

    Mr. Kelly added, “Pelareorep’s clinical data across multiple tumors is striking and represents the potential for a true backbone immunotherapy to address many in-need indications. Importantly, the data show that pelareorep creates a robust immunologic response in difficult tumors and increases survival in a patient population where survival has historically evaded most patients. With a renewed focus and sharpened clinical development plan, we believe we will move pelareorep forward effectively and efficiently to a place where potential partners will see the value of a de-risked immunotherapy. I am excited to get to work accelerating development and unlocking significant value for stakeholders.”

    Pelareorep, an intravenously-administered immunotherapeutic agent, has been granted FDA Fast Track designation by the U.S. Food and Drug Administration (FDA) in metastatic pancreatic ductal adenocarcinoma (mPDAC) and HR+/HER2- metastatic breast cancer (mBC). It has delivered compelling results in mPDAC, a high-value indication with significant unmet need. In Phase 1 and 2 trials involving more than 140 mPDAC patients, pelareorep has delivered a >60% objective response rate in tumor evaluable patients in the most recent study, which is more than double the benefit observed in historical control trials, and, separately, two-year survival rates 4-6 times those observed in control patients or against the benchmark in prior studies.

    In mBC, pelareorep recorded a meaningful survival benefit in two randomized Phase 2 studies of over 100 combined mBC patients, IND-213 and BRACELET-1. Phase 2 objective response rate data in second-line or later unresectable squamous cell carcinoma of the anal canal (SCCA) patients continue to exceed historical data for treatment with a checkpoint inhibitor alone. These consistent efficacy signals, in combination with multiple chemotherapies and checkpoint inhibitors, uniquely position pelareorep as a high-potential asset for further development in-house and/or through strategic partnerships. Pelareorep also has a well-defined and favorable safety profile based on data from >1,100 patients across multiple tumor types.

    As a material inducement to Mr. Kelly’s appointment as Chief Executive Officer, and in accordance with NASDAQ Listing Rule 5635(c)(4), Mr. Kelly has been awarded an initial stock option grant exercisable for 2,850,000 shares with an exercise price of CAD$0.57, vesting equally over three years. He also received a performance-based stock option grant exercisable for 1,900,000 shares with an exercise price of CAD$0.57, which will vest upon the achievement of certain financing objectives. All stock option grants have a term of 5 years from the date of grant. The Company also granted Mr. Kelly restricted stock units, which will entitle him to receive that number of Common Shares equal to 2% of the Company’s then outstanding common shares upon the Company entering into a definitive agreement for certain transactions providing for the acquisition of the Company or the exclusive license of pelareorep. Each of these awards is intended to align Mr. Kelly’s long-term incentives with the creation of shareholder value. CONTINUED… Read these full press releases and more news for ONCY at: https://www.financialnewsmedia.com/news-oncy/

    Other recent oncology developments in the biotech industry of note include:

    Novartis AG (NYSE: NVS) recently announced topline results from a pre-specified interim analysis of the Phase III PSMAddition trial. The trial met its primary endpoint with a statistically significant and clinically meaningful benefit in radiographic progression-free survival (rPFS) with a positive trend in overall survival (OS) in patients with prostate-specific membrane antigen (PSMA)-positive metastatic hormone-sensitive prostate cancer (mHSPC) treated with radioligand therapy (RLT), Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan), in combination with standard of care (SoC) versus SoC alone1. In PSMAddition, the SoC is a combination of androgen receptor pathway inhibitor (ARPI) therapy and androgen deprivation therapy (ADT)3.

    Almost all mHSPC patients ultimately progress to metastatic castration-resistant prostate cancer (mCRPC)4. There is a need for additional treatment options with novel mechanisms of action that further delay progression, prolong OS and improve disease control compared to the current SoC, while showing a favorable safety and tolerability profile.

    BioNTech SE (NASDAQ: BNTX) and Bristol Myers Squibb (BMY, “BMS”) recently announced that the companies have entered into an agreement for the global co-development and co-commercialization of BioNTech’s investigational bispecific antibody BNT327 across numerous solid tumor types. Under the agreement, BioNTech and BMS will work jointly to broaden and accelerate the development of this clinical candidate.

    BioNTech’s BNT327, a next-generation bispecific antibody candidate targeting PD-L1 and VEGF-A, is currently being evaluated in multiple ongoing trials with more than 1,000 patients treated to date, including global Phase 3 trials with registrational potential evaluating BNT327 as first-line treatment in extensive stage small cell lung cancer (“ES-SCLC”) and non-small cell lung cancer (“NSCLC”). A global Phase 3 trial evaluating the candidate in triple negative breast cancer (“TNBC”) is planned to start by the end of 2025. Preliminary data from ongoing trials underscore the potential for combining anti-PD-L1 and anti-VEGF-A – two well-established therapeutic targets – into a single molecule to deliver synergistic clinical benefits for patients across multiple tumor types.

    Arvinas, Inc. (NASDAQ: ARVN) and Pfizer Inc. (NYSE: PFE) recently announced detailed results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus fulvestrant in adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer (MBC) whose disease progressed following prior treatment with cyclin-dependent kinase (CDK) 4/6 inhibitors and endocrine therapy. These data, which were highlighted in the American Society of Clinical Oncology (ASCO®) press briefing and selected for Best of ASCO, will be presented today in a late-breaking oral presentation (Abstract LBA1000) and have been simultaneously published in the New England Journal of Medicine.

    In the trial, vepdegestrant demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) among patients with an estrogen receptor 1 (ESR1) mutation, reducing the risk of disease progression or death by 43% compared to fulvestrant [Hazard Ratio (HR)=0.57 (95% CI 0.42–0.77); 2-sided P<0.001]. The median PFS, as assessed by blinded independent central review (BICR), was 5.0 months with vepdegestrant versus 2.1 months with fulvestrant. Investigator-assessed PFS was consistent with the BICR-assessed PFS. In patients with ESR1 mutations, vepdegestrant demonstrated a consistent PFS benefit over fulvestrant across all pre-specified subgroups. The trial did not reach statistical significance in improvement in PFS in the intent-to-treat (ITT) population, with a median PFS of 3.7 months for vepdegestrant versus 3.6 for fulvestrant [HR=0.83 (95% CI 0.68–1.02); 2-sided P=0.07].

    About FN Media Group:

    At FN Media Group, via our top-rated online news portal at www.financialnewsmedia.com, we are one of the very few select firms providing top tier one syndicated news distribution, targeted ticker tag press releases and stock market news coverage for today’s emerging companies. #pressreleases #tickertagpressreleases

    Follow us on Facebook to receive emerging news updates: https://www.facebook.com/financialnewsmedia

    Follow us on Twitter for real time Breaking News: https://twitter.com/FNMgroup

    Follow us on Linkedin: https://www.linkedin.com/in/financialnewsmedia/

    DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated forty nine hundred dollars for news coverage of the current press releases issued by Oncolytics Biotech® Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

    This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

    Contact Information:

    Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757 

    SOURCE: FN Media Group

    The MIL Network –

  • MIL-OSI: Draganfly Announces Pricing of US$13.75 Million Public Offering

    Source: GlobeNewswire (MIL-OSI)

    Saskatoon, SK., June 11, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the pricing of its public offering (the “Offering”) of 5,500,000 units, with each unit consisting of one common share and one warrant to purchase one common share. Each unit is to be sold at a public offering price of US$2.50, for gross proceeds of approximately US$13.75 million, before deducting placement agent discounts and offering expenses. The warrants will have an exercise price of CA$5.0768 (or US$3.71) per share, are exercisable immediately and will expire five years following the date of issuance.

    Maxim Group LLC is acting as sole placement agent for the Offering.

    Draganfly currently intends to use the net proceeds from the Offering for general corporate purposes, including to fund its capabilities to meet demand for its new products including growth initiatives and/or for working capital requirements including the continuing development and marketing of the Company’s core products, potential acquisitions and research and development. The Offering is expected to close on or about June 12, 2025, subject to the satisfaction of customary closing conditions.

    The Offering is subject to customary closing conditions including receipt of all necessary regulatory approvals, including approval of the Canadian Securities Exchange and notification to the Nasdaq Stock Market.

    The Offering is being made pursuant to an effective shelf registration statement on Form F-10, as amended, (File No. 333-271498) previously filed with and subsequently declared effective by the U.S. Securities and Exchange Commission (“SEC”) on July 5, 2023 and the Company’s Canadian short form base shelf prospectus dated June 30, 2023 (the “Base Shelf Prospectus”). Draganfly will offer and sell the securities in the United States only. No securities will be offered or sold to Canadian purchasers.

    A preliminary prospectus supplement and accompanying Base Shelf Prospectus relating to the Offering and describing the terms thereof has been filed with the applicable securities commissions in Canada and with the SEC in the United States and is available for free by visiting the Company’s profiles on the SEDAR+ website maintained by the Canadian Securities Administrators at www.sedarplus.ca or the SEC’s website at www.sec.gov, as applicable. A final prospectus supplement with the final terms will be filed with the securities regulatory authorities in the Canadian provinces of British Columbia, Saskatchewan and Ontario and the SEC. Copies of the preliminary prospectus supplements, accompanying Base Shelf Prospectus, and final prospectus supplement, when available, relating to the Offering may be obtained by contacting Maxim Group LLC, at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Syndicate Department, or by telephone at (212) 895-3745 or by email at syndicate@maximgrp.com.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

    About Draganfly

    Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) is a pioneer in drone solutions, AI-driven software, and robotics. With over 25 years of innovation, Draganfly has been at the forefront of drone technology, providing solutions for public safety, agriculture, industrial inspections, security, mapping, and surveying. The Company is committed to delivering efficient, reliable, and industry-leading technology that helps organizations save time, money, and lives.

    Media Contact
    media@draganfly.com

    Company Contact
    Email: info@draganfly.com

    Forward Looking Statements

    Certain statements contained in this news release may constitute “forward-looking statements” or “forward-looking information” within the meaning of applicable securities laws. Such statements, based as they are on the current expectations of management, inherently involve numerous important risks, uncertainties and assumptions, known and unknown. In this news release, such forward-looking statements include, but are not limited to, statements regarding the timing, size and expected gross proceeds of the Offering, the satisfaction of customary closing conditions related to the Offering and sale of securities, the intended use of proceeds, and Draganfly’s ability to complete the Offering. Closing of the Offering is subject to numerous factors, many of which are beyond Draganfly’s control, including but not limited to, the failure of the parties to satisfy certain closing conditions, and other important factors disclosed previously and from time to time in Draganfly’s filings with the securities regulatory authorities in the Canadian provinces of British Columbia, Ontario and Saskatchewan and with the SEC. Actual future events may differ from the anticipated events expressed in such forward-looking statements. Draganfly believes that expectations represented by forward-looking statements are reasonable, yet there can be no assurance that such expectations will prove to be correct. The reader should not place undue reliance, if any, on any forward-looking statements included in this news release. These forward-looking statements speak only as of the date made, and Draganfly is under no obligation and disavows any intention to update publicly or revise such statements as a result of any new information, future event, circumstances or otherwise, unless required by applicable securities laws.‎ Investors are cautioned not to unduly rely on these forward-looking statements and are encouraged to read the Offering documents, as well as Draganfly’s continuous disclosure documents, including its current annual information form, as well as its audited annual consolidated financial statements which are available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov/edgar.

    The MIL Network –

  • MIL-OSI: Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

    Source: GlobeNewswire (MIL-OSI)

    WHITE BEAR LAKE, Minn., June 11, 2025 (GLOBE NEWSWIRE) — Envoy Medical®, Inc. (NASDAQ: COCH) (“Envoy Medical”), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear’s natural anatomy, today announced that Brent Lucas, CEO of Envoy Medical, will present live at the Life Sciences Virtual Investor Frum hosted by VirtualInvestorConferences.com, on June 12th, 2025.

    DATE: June 12th
    TIME: 3pm Eastern
    LINK: REGISTER HERE
    Available for 1×1 meetings: June 12th through the 17th

    This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

    It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.  

    Learn more about the event at www.virtualinvestorconferences.com.

    Recent Company Highlights

    • June 10, 2025 – Envoy Medical’s Pivotal Clinical Trial for Fully-Implanted Acclaim® Cochlear Implant On Track After First Month Follow Up
    • May 13, 2025 – Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

    About Virtual Investor Conferences®

    Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

    Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

    About Envoy Medical, Inc.

    Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance, and ultimately quality of life.

    About the Fully Implanted Acclaim® Cochlear Implant

    We believe the fully implanted Acclaim Cochlear Implant (“Acclaim CI”) is a first-of-its-kind hearing device. Envoy Medical’s fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound. The device is powered by a rechargeable battery and has an external charger to charge the internal device when necessary. In addition, patients are given an external remote or programmer to adjust settings or turn the device on or off.

    The Acclaim CI is designed to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids. The Acclaim CI is expected to be indicated for adults who have been deemed adequate candidates by a qualified physician.

    The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019.

    For more information on the trial, investors can visit clinicaltrials.gov or www.envoymedical.com/acclaim-pivotal.

    CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

    About the Esteem® Fully Implanted Active Middle Ear Implant (FI-AMEI)

    The Esteem fully implanted active middle ear implant (FI-AMEI) is the only FDA-approved, fully implanted hearing device for adults diagnosed with moderate to severe sensorineural hearing loss allowing for 24/7 hearing capability using the ear’s natural anatomy. The Esteem FI-AMEI hearing implant is invisible and requires no externally worn components and nothing is placed in the ear canal for it to function. Unlike hearing aids, you never put it on or take it off. You can’t lose it. You don’t clean it. The Esteem FI-AMEI hearing implant offers true 24/7 hearing. Patients are given an external remote or “personal programmer” to adjust volume, switch between hearing profiles, or turn the device on or off.

    Important safety information for the Esteem FI-AMEI can be found at: https://www.envoymedical.com/safety-information.

    Additional Information and Where to Find It

    Copies of the documents filed by Envoy Medical with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.

    Forward-Looking Statements
    This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-Looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. Such statements may include, but are not limited to, statements regarding the expectations of Envoy Medical concerning the outlook for its business, productivity, plans and goals for future operational improvements and capital investments; the timing and results of IRB approvals, site documents, logistics or activations, enrollments, follow-up visits, data, and clinical trials of the Acclaim CI, and the participation or any changes in participation of any subjects, institutions or healthcare professionals in such trials; the Acclaim CI being the first to market fully implanted cochlear implant; the safety, performance, and market acceptance of the Acclaim CI; and any information concerning possible or assumed future operations of Envoy Medical. The forward-looking statements contained in this press release reflect Envoy Medical’s current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause its actual results to differ significantly from those expressed in any forward-looking statement. Envoy Medical does not guarantee that the events described will happen as described (or that they will happen at all). These forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to changes in the market price of shares of Envoy Medical’s Class A Common Stock; changes in or removal of Envoy Medical’s shares inclusion in any index; Envoy Medical’s success in retaining or recruiting, or changes required in, its officers, key employees or directors; unpredictability in the medical device industry, the regulatory process to approve medical devices, and the clinical development process of Envoy Medical products; competition in the medical device industry, and the failure to introduce new products and services in a timely manner or at competitive prices to compete successfully against competitors; disruptions in relationships with Envoy Medical’s suppliers, or disruptions in Envoy Medical’s own production capabilities for some of the key components and materials of its products; changes in the need for capital and the availability of financing and capital to fund these needs; changes in interest rates or rates of inflation; legal, regulatory and other proceedings could be costly and time-consuming to defend; changes in applicable laws or regulations, or the application thereof on Envoy Medical; a loss of any of Envoy Medical’s key intellectual property rights or failure to adequately protect intellectual property rights; the effects of catastrophic events, including war, terrorism and other international conflicts; and other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward Looking Statements” in the Annual Report on Form 10-K filed by Envoy Medical on March 31, 2025, and in other reports Envoy Medical files, with the SEC. If any of these risks materialize or Envoy Medical’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. While forward-looking statements reflect Envoy Medical’s good faith beliefs, they are not guarantees of future performance. Envoy Medical disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based only on information currently available to Envoy Medical.

    About Virtual Investor Conferences®

    Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

    Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

    CONTACTS:
    Envoy Medical Investor Contact
    Phil Carlson
    KCSA Strategic Communications
    212.896.1233
    Envoy@kcsa.com

    Virtual Investor Conferences
    John M. Viglotti
    SVP Corporate Services, Investor Access
    OTC Markets Group
    (212) 220-2221
    johnv@otcmarkets.com

    The MIL Network –

  • MIL-OSI: Robinhood Markets, Inc. Reports May 2025 Operating Data

    Source: GlobeNewswire (MIL-OSI)

    MENLO PARK, Calif., June 11, 2025 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for May 2025.

    • Funded Customers at the end of May were 25.9 million (up about 5 thousand from April 2025, up 1.8 million year-over-year). In May, Funded Customers grew by approximately 5 thousand after the impact of required escheatment of approximately 100 thousand low-balance accounts.
    • Total Platform Assets at the end of May were $255 billion (up 10% from April 2025, up 89% year-over-year). Net Deposits were $3.5 billion in May, or a 18% annualized growth rate relative to April 2025 Total Platform Assets. Over the last twelve months, Net Deposits were $59.1 billion, or an annual growth rate of 44% relative to May 2024 Total Platform Assets.
    • Equity Notional Trading Volumes were $180.5 billion (up 14% from April 2025, up 108% year-over-year). Options Contracts Traded were 179.8 million (up 7% from April 2025, up 36% year-over-year). Crypto Notional Trading Volumes were $11.7 billion (up 36% from April 2025, up 65% year-over-year).
    • Margin balances at the end of May were $9.0 billion (up 7% from the end of April 2025, up 100% year-over-year).
    • Total Cash Sweep balances at the end of May were $30.8 billion (up 7% from the end of April 2025, up 52% year-over-year).
    • Total Securities Lending Revenue in May was $33 million (up 32% from April 2025, up 43% year-over-year).
    • May 2025 results do not include the benefit of the Bitstamp acquisition which closed on June 2, 2025, including its approximately 500 thousand funded customers.
      May
    2025    		 April
    2025    		 M/M
    Change    		 May
    2024    		 Y/Y
    Change
    (M – in millions, B – in billions)          
    Funded Customer Growth (M)          
    Funded Customers 25.9 25.9 – 24.1 +7%
               
    Asset Growth ($B)          
    Total Platform Assets $255.3 $232.3 +10% $135.0 +89%
    Net Deposits1 $3.5 $6.8 NM $3.6 NM
               
    Trading          
    Trading Days (Equities and Options) 21 21 – 22 (5%)
    Total Trading Volumes          
    Equity ($B) $180.5 $157.8 +14% $86.8 +108%
    Options Contracts (M) 179.8 167.5 +7% 131.9 +36%
    Crypto ($B) $11.7 $8.6 +36% $7.1 +65%
               
    Daily Average Revenue Trades (DARTs) (M)
    Equity 2.3 2.3 – 2.0 +15%
    Options 1.2 1.2 – 0.8 +50%
    Crypto 0.5 0.5 – 0.3 +67%
               
    Customer Margin and Cash Sweep ($B)        
    Margin Book $9.0 $8.4 +7% $4.5 +100%
    Total Cash Sweep $30.8 $28.9 +7% $20.3 +52%
    Gold Cash Sweep $28.8 $26.9 +7% $19.6 +47%
    Non-Gold Cash Sweep $2.0 $2.0 – $0.7 186%
               
    Total Securities Lending Revenue ($M) $33 $25 +32% $23 +43%

    Note: Does not reflect the acquisition of Bitstamp, which closed on June 2, 2025.

    1. Net Deposits do not include results from TradePMR.

    For definitions and additional information regarding these metrics, please refer to Robinhood’s full monthly metrics release, which is available on investors.robinhood.com.

    The information in this release is unaudited and the information for the months in the most recent fiscal quarter is preliminary, based on Robinhood’s estimates, and subject to completion of financial closing procedures. Final results for the most recent fiscal quarter, as reported in Robinhood’s quarterly and annual filings with the U.S. Securities and Exchange Commission (“SEC”), might vary from the information in this release.

    About Robinhood

    Robinhood Markets, Inc. (NASDAQ: HOOD) transformed financial services by introducing commission-free stock trading and democratizing access to the markets for millions of investors. Today, Robinhood lets you trade stocks, options, futures (which includes options on futures, swaps, and event contracts), and crypto, invest for retirement, and earn with Robinhood Gold. Headquartered in Menlo Park, California, Robinhood puts customers in the driver’s seat, delivering unprecedented value and products intentionally designed for a new generation of investors. Additional information about Robinhood can be found at www.robinhood.com.

    Robinhood uses the “Overview” tab of its Investor Relations website (accessible at investors.robinhood.com/overview) and its Newsroom (accessible at newsroom.aboutrobinhood.com), as means of disclosing information to the public in a broad, non-exclusionary manner for purposes of the SEC Regulation Fair Disclosure (Reg. FD). Investors should routinely monitor those web pages, in addition to Robinhood’s press releases, SEC filings, and public conference calls and webcasts, as information posted on them could be deemed to be material information.

    “Robinhood” and the Robinhood feather logo are registered trademarks of Robinhood Markets, Inc. All other names are trademarks and/or registered trademarks of their respective owners.

    Contacts

    Investor Relations
    ir@robinhood.com

    Media
    press@robinhood.com

    The MIL Network –

  • MIL-OSI: Aterian’s PurSteam and Mueller Living Brands Launch Products in Walmart Stores

    Source: GlobeNewswire (MIL-OSI)

    SUMMIT, N.J., June 11, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the national launch of two of its most innovative home appliances – the PurSteam Steam Station Max and the Mueller Living Cordless Portable Vacuum Sealer – now available nationwide across Walmart locations.

    “These launches reflect Aterian’s broader mission to expand our omni-channel presence by bringing high-quality consumer products to both digital and physical retail platforms,” said Arturo Rodriguez, Chief Executive Officer of Aterian. “The increased brand visibility, coupled with mass-market accessibility, is designed to strengthen the Company’s growth trajectory and retail partnerships.”

    Product Launch Descriptions

    • The PurSteam Steam Station Max delivers premium ironing performance at an accessible price point. Featuring rapid 1.5-minute preheat, strong continuous steam output, and a large 50.7 oz water tank, it’s built for speed and convenience. A ceramic soleplate ensures smooth gliding across all fabrics, while integrated anti-calc, anti-drip, and auto shut-off features enhance safety and extend appliance life.
    • Also launching is the Mueller Living Cordless Portable Vacuum Sealer, a compact, high-performance food preservation tool that seals up to 60 bags on a single charge. With universal compatibility, fast 3-hour charging, and a cordless design, it’s ideal for everyday kitchens, meal prepping, or on-the-go storage.

    “Whether it’s the commercial-grade power of our PurSteam Steam Station Max or the flexible, space-saving design of our Mueller Living Cordless Portable Vacuum Sealer, our goal is to deliver intelligent products that make life at home better,” Mr. Rodriguez continued. “These launches exemplify our commitment to combining thoughtful design with the power, safety, and everyday convenience that households demand.”

    About PurSteam
    PurSteam, an Aterian brand, is dedicated to revolutionizing the way people clean and care for their homes. From high-performance steam irons to state-of-the-art steam mops, PurSteam delivers products that combine advanced technology, superior quality, and exceptional value. To learn more, visit www.pursteam.com.

    About Mueller Living
    Mueller Living, part of the Aterian brand portfolio, believes the kitchen is the heart of the home. Known for its premium, affordable kitchen tools, Mueller Living inspires cooks of all levels with products that blend comfort, design, and durability. To learn more, visit www.muellerliving.com.

    About Aterian, Inc.
    Aterian, Inc. (Nasdaq: ATER) is a technology-enabled consumer products company that builds and acquires leading e-commerce brands across multiple categories, including home and kitchen appliances, health and wellness, and air quality devices. The Company sells across the world’s largest online marketplaces, including Amazon, Walmart, and Target as well as its own direct-to-consumer websites. Aterian’s brands include Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions, and Photo Paper Direct. To learn more, visit www.aterian.io.

    Forward Looking Statements
    All statements other than statements of historical facts included in this press release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements including, in particular, our ability to expand our omni-channel presence, and strengthen our growth trajectory and retail partnerships. These forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks and uncertainties and other factors, all of which are difficult to predict and many of which are beyond our control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to, those related to our ability to continue as a going concern, the effect of tariffs and other costs on our results, our ability to continue to operate following our reduction in workforce, our ability to meet financial covenants with our lenders, our ability to maintain and to grow market share in existing and new product categories; our ability to continue to profitably sell the SKUs we operate; our ability to maintain Amazon’s Prime badge on our seller accounts or reinstate the Prime badge in the event of any removal of such badge by Amazon; our ability to create operating leverage and efficiency when integrating companies that we acquire, including through the use of our team’s expertise, the economies of scale of our supply chain and automation driven by our platform; those related to our ability to grow internationally and through the launch of products under our brands and the acquisition of additional brands; those related to consumer demand, our cash flows, financial condition, forecasting and revenue growth rate; our supply chain including sourcing, manufacturing, warehousing and fulfillment; our ability to manage expenses, working capital and capital expenditures efficiently; our business model and our technology platform; our ability to disrupt the consumer products industry; our ability to generate profitability and stockholder value; international tariffs and trade measures; inventory management, product liability claims, recalls or other safety and regulatory concerns; reliance on third party online marketplaces; seasonal and quarterly variations in our revenue; acquisitions of other companies and technologies and our ability to integrate such companies and technologies with our business; our ability to continue to access debt and equity capital (including on terms advantageous to the Company) and the extent of our leverage; and other factors discussed in the “Risk Factors” section of our most recent periodic reports filed with the Securities and Exchange Commission (“SEC”), all of which you may obtain for free on the SEC’s website at www.sec.gov.

    Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, even if subsequently made available by us on our website or otherwise. We do not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

    Investor Contact:

    The Equity Group
    Devin Sullivan, Managing Director
    dsullivan@theequitygroup.com

    Conor Rodriguez, Associate
    crodriguez@theequitygroup.com

    The MIL Network –

  • MIL-OSI: AMSC Announces Pricing of $115 Million Public Offering of Common Stock

    Source: GlobeNewswire (MIL-OSI)

    AYER, Mass., June 11, 2025 (GLOBE NEWSWIRE) — American Superconductor Corporation (Nasdaq: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™ and protect and expand the capability and resiliency of our Navy’s fleet, announced today that it has priced its underwritten public offering of 4,125,000 shares of its common stock at a public offering price of $28.00 per share. AMSC expects the gross proceeds from this offering to be $115,500,000, before deducting the underwriting discounts and commissions and other estimated offering expenses. AMSC intends to use the net proceeds from this offering for working capital and general corporate purposes, including potential strategic acquisitions. AMSC has granted the underwriters a 30-day option to purchase up to 618,750 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. AMSC expects to close the offering, subject to customary conditions, on or about June 12, 2025.

    Oppenheimer & Co. Inc. is acting as the sole book-running manager for the offering. Craig-Hallum Capital Group LLC is acting as lead manager and Roth Capital Partners is acting as co-manager for the offering.

    A shelf registration statement relating to the shares of common stock to be issued in the proposed offering was filed with the Securities and Exchange Commission (SEC) and is effective. A preliminary prospectus supplement and accompanying prospectus describing the terms of the offering has been filed with the SEC and a final prospectus supplement will be filed with the SEC. Copies of the final prospectus supplement and the accompanying prospectus relating to the securities being offered may also be obtained, when available, from Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8563, or by email at EquityProspectus@opco.com. Electronic copies of the final prospectus supplement and accompanying prospectus will also be available on the SEC’s website at http://www.sec.gov.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, among other things, statements regarding the completion of the offering, the expected gross proceeds therefrom, the intended use of net proceeds therefrom, and other statements containing the words “intends,” “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions. Such forward-looking statements represent management’s current expectations and are inherently uncertain. There are a number of important factors that could materially impact the value of AMSC’s common stock or cause actual results to differ materially from those indicated by such forward-looking statements. These important factors include, but are not limited to: the risk and uncertainties associated with market conditions, satisfaction of customary closing conditions related to the public offering, as well as risks and uncertainties in AMSC’s business, including those risks discussed in the “Risk Factors” section in the preliminary prospectus supplement related to the offering and in Part I, Item 1A of AMSC’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025 and AMSC’s other reports filed with the SEC. These important factors, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Any such forward-looking statements represent management’s estimates as of the date of this press release. While AMSC may elect to update such forward-looking statements at some point in the future, AMSC disclaims any obligation to do so, even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing its views as of any date subsequent to the date of this press release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

    Contacts

    Nicol Golez
    Phone: 978-399-8344
    Nicol.Golez@amsc.com 

    Investor Relations
    Carolyn Capaccio
    (212) 838-3777
    amscIR@allianceadvisors.com

    Public Relations
    RooneyPartners
    Joe Luongo
    (914) 906-5903
    jluongo@rooneypartners.com 

    The MIL Network –

  • MIL-OSI: Conavi Medical to Present at the Life Sciences Virtual Investor Forum June 12th

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 11, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on June 12th, 2025

    DATE: June 12th
    TIME: 2:00 PM ET
    LINK: REGISTER HERE

    This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

    It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.

    Learn more about the event at www.virtualinvestorconferences.com.

    Recent Company Highlights

    • Upsized $20 million CAD financing led by U.S. institutional investors is expected to support finalizing product development of the next-generation Novasight Hybrid system, submit for regulatory clearance and enable commercial launch
    • New U.S. intracoronary imaging guidelines from the American College of Cardiology and recent peer-reviewed research strongly validate Novasight’s unique value proposition
    • U.S. FDA 510(k) submission remains on track for calendar Q3 2025

    About Conavi Medical
    Conavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. The Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration; and regulatory approval for clinical use from Health Canada, China’s National Medical Products Administration, and Japan’s Ministry of Health, Labor and Welfare. For more information, visit conavi.com.

    About Virtual Investor Conferences®
    Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

    Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.  Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

    Forward-Looking Statements
    This press release includes forward-looking information or forward-looking statements within the meaning of applicable securities laws regarding Conavi and its business, which may include, but are not limited to, statements with respect to the anticipated use of proceeds from the April 2025 public offering, Conavi’s exposure to the U.S. investment community, the commercialization and development of the Novasight Hybrid System and the achievement and timeline of key milestones towards commercialization and development of the Novasight Hybrid System. All statements that are, or information which is, not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking information or statements”. Often but not always, forward-looking information or statements can be identified by the use of words such as “shall”, “intends”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate” “anticipate” or any variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “might”, “can”, “could”, “would” or “will” be taken, occur, lead to, result in, or, be achieved. Such statements are based on the current expectations and views of future events of the management of the Company. They are based on assumptions and subject to risks and uncertainties. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including, without limitation, those listed in the “Risk Factors” section of the short form prospectus dated April 15, 2025 and the joint information circular of the Company dated August 30, 2024 (both of which are on the Company’s profile at sedarplus.ca ). Although Conavi has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Conavi does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
    No regulatory authority has approved or disapproved the content of this press release.
    Neither the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

    Contacts:

    Conavi Medical
    Stefano Picone
    Chief Financial Officer
    ir@conavi.com
    (416) 483-0100

    Virtual Investor Conferences
    John M. Viglotti
    SVP Corporate Services, Investor Access
    OTC Markets Group
    (212) 220-2221
    johnv@otcmarkets.com

    The MIL Network –